Longdom Conferences extends immense pleasure and honor by inviting you to attend “International Conference on Fungal Infections and Treatments” scheduled during Nov 25-26, 2020 in New York, USA. Fungal Infections Conference will be focusing on the theme “Current Advancement on Fungal infections and Care" to enhance and explore knowledge among academicians and industry personnel. This Fungal Infections Conference will be having sessions on antifungal drugs, antifungal treatments, Valley fever, yeast infection and its related subjects to establish a connection for exchanging ideas. Detailed agenda of Fungal infections will have keynote presentations, plenary sessions, oral sessions, panel discussion, posters presentations, workshops, symposia, and young researchers’ forum.

International Conference on Fungal Infections and Treatments will be the world’s foremost conference for all eminent professionals dealing with fungal infection and research science to come together and enrich this event with their research findings and experiences. Fungal infection Conference offers over 20 scientific sessions from different research areas in the field of fungal infection and advanced fungal infection research science in the form of keynote presentations, plenary sessions, oral sessions, panel discussions, posters presentations, workshops, symposia, and young researchers’ forum.

Fungal infection conference is going to be held in New york, USA during November 25-26, 2020. Fungal Infections will address the succeeding research and development in the field of antifungal treatments, Aspergillosis, Candidiasis, Cryptococcal meningitis, Fungal disease outbreaks, Eye infections, Jock itch, Rheumatoid arthritis and this will provide a major opportunity for collaboration and interaction among all research scholars and industry personnel.

Fungal infection conference will become the leading platform in bringing together all experts and beginners for a friendly and effective research-oriented discussion. The goal of Longdom conferences is to bring together scientists at every level from diverse disciplines to understand and discuss throughout the programmed sessions and comfortable gatherings. All these opportunities will support the professional growth of younger scientists that will promote future collaborations and enhance participation and contribution to their exciting research work.

About Venue: New York City (NYC)

Fungal Infections is scheduled in New York City (NYC), which is the most populous city in the USA. The total population of 8,398,748 distributed over about 302.6 square miles (784 km2), New York is also the most densely populated major city in the United States. It is located at the southern tip of the USA. The city is the largest metropolitan area in the world by urban landmass, with almost 20 million people in its metropolitan statistical area and approximately 23 million in its combined statistical area. Many landmarks in New York City are well known, including three of the world's most visited tourist attractions. i.e. Statue of Liberty, Empire State Building, Central Park, Times Square, Brooklyn Bridge, Fifth Avenue, Rockefeller Center, Grand Central Terminal, High Line, September 11 Memorial and many more.

According to this research report, the global market for Fungal Infections is projected to show a robust growth of 6.4 per cent in the CAGR during 2019- 2023.

The perspective of the Microbiology Conference is to set up research to help people understand how techniques have advanced in the field of Microbiology and how the field has developed in recent years.

In 2017, the global antifungal drugs market size was valued at USD 11.3 billion. Growing prevalence of fungal infections such as aspergillosis and candidiasis is one of the key factors propelling the market. Fungal infections encompass both systemic and superficial infections including infection of the skin, eye, mouth, and vagina. Antifungal products with fungicidal activity are mostly used to treat a wide array of diseases, such as athlete's foot, ringworm, and fungal meningitis, caused by fungal agents. Moreover, mounting cases of patients suffering from hospital-acquired or nosocomial infections and infectious diseases are poised to stoke the growth of the market during the forecast period.

U.S. Antifungal Drugs Market

To learn more about this report, request a free sample copy

Fungal diseases are a public health problem as they can affect any individual. However, there is severe threat of fungal infections to people with weak immune response such as patients with AIDS. There is a high possibility of development of opportunistic fungal infections in these patients. According to statistics published by the Centers of Disease Control and Prevention in 2016, every year, nearly 220,000 new individuals are affected by cryptococcal meningitis, which is brain infection and has resulted in 181,000 deaths per year around the world. Most of the deaths are reported in sub-Saharan Africa, as the prevalence of HIV/AIDS is more in these countries.

In addition, ongoing public-private partnership agreements in the pharmaceutical industry for development of novel therapeutics are projected to offer tremendous growth opportunities to the market. For example, CARB-X, an international public-private partnership, is anticipated to provide around USD 350 million in the coming five years to boost the R & D pipeline. Partners involved are the U.S. Department of Health and Human Services, Antimicrobial Resistance Centre in England, and Boston University School of Law.

Fungal Infections is the investigation of microorganisms (otherwise called organisms), which are unicellular or cellgroup creatures and irresistible operators too little to even consider being seen with the unaided eye. This incorporates eukaryotes (life forms with a core, for example, growths and protists, and prokaryotes (creatures without a core, for example, microscopic organisms.

In recent years, the market for Fungal Infections has seen significant growth directly on the back of the increasing number of procedures for Microbial techniques.

Contact:

Michael Smith

Program Manager

Contact No: +32 800 753 58

WhatsApp No: +32466903213